The significant policy change is based on a small study that has not undergone peer review and did not evaluate the vaccine’s protection against severe disease, a key metric of success.
South Africa Abandons Oxford-AstraZeneca Covid-19 Vaccine In Favor Of Unapproved Johnson & Johnson Shot
